Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis
Author(s) -
Yukiko Tomioka,
Shusuke Numata,
Makoto Kinoshita,
Hidehiro Umehara,
Shin-ya Watanabe,
Masahito Nakataki,
Yoshimi Iwayama,
Tomoko Toyota,
Masashi Ikeda,
Hidenaga Yamamori,
Shinji Shimodera,
Atsushi Tajima,
Ryota Hashimoto,
Nakao Iwata,
Takeo Yoshikawa,
Tetsuro Ohmori
Publication year - 2018
Publication title -
journal of psychiatry and neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.767
H-Index - 99
eISSN - 1488-2434
pISSN - 1180-4882
DOI - 10.1503/jpn.170053
Subject(s) - mendelian randomization , schizophrenia (object oriented programming) , odds ratio , medicine , pyridoxal , meta analysis , confidence interval , population , cohort study , psychiatry , endocrinology , gastroenterology , genotype , biology , genetics , biochemistry , gene , environmental health , phosphate , genetic variants
We found decreased serum pyridoxal levels in patients with schizophrenia in this observational study. However, we failed to obtain data supporting a causal relationship between pyridoxal levels and schizophrenia risk using the MR approach.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom